The CALM Study – to evaluate the effect of the NEUROMARK System on symptoms in adults with chronic migraine.
Individuals may qualify to participate if they:
- Are ≥18 years of age.
- Have migraines for 3 months or longer.
- Must have 15 or more headache days a month with 8 being migraine
Length of study: 12 months
Number of visits: 8
Compensation for time and travel
For more information:
John Lanza, MD - Principal Investigator
Matthew Ericksen, DO – Sub-Investigator
Timothy Tudor, DO - Sub-Investigator
Port St. Lucie office, contact Erica Riccard at
Scott Powell, MD - Principal Investigator
Jeremy Rogers, MD - Sub-Investigator
Brandon office, contact Ciarra Kennedy at